Balzarini Madeline, Tong Joel, Gui Weijun, Jayalath Isuru M, Schell Bin-Bin, Kodadek Thomas
Skaggs Graduate School of Chemical and Biological Sciences , 120 Scripps Way, Jupiter, Florida 33458, United States.
Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, 120 Scripps Way, Jupiter, Florida 33458, United States.
ACS Chem Biol. 2024 Nov 15;19(11):2323-2335. doi: 10.1021/acschembio.4c00422. Epub 2024 Oct 22.
Targeted protein degradation (TPD) is a promising strategy for drug development. Most degraders function by forcing the association of the target protein (TP) with an E3 Ubiquitin (Ub) ligase, which, in favorable cases, results in the polyubiquitylation of the TP and its subsequent degradation by the 26S proteasome. An alternative strategy would be to create chemical dimerizers that bypass the requirement for polyubiquitylation by recruiting the target protein directly to the proteasome. Direct-to-proteasome degraders (DPDs) may exhibit different characteristics than ubiquitin-dependent degraders, but few studies of this type of TPD have been published, largely due to the dearth of suitable proteasome ligands. To facilitate studies of DPDs, we report here a mammalian cell line in which the HaloTag protein is fused to the proteasome via Rpn13, one of the ubiquitin receptors. In these cells, a chloroalkane serves as a covalent proteasome ligand surrogate. We show that chimeric molecules comprised of a chloroalkane linked to a ligand for the BET family of proteins or the Cdk2/7/9 family of kinases result in ubiquitin-independent degradation of some of these target proteins. We use this system, the first that allows facile degradation of native proteins in a ubiquitin-independent fashion, to probe two issues: the effect of varying the length of the linker connecting the chloroalkane and the target ligand and the selectivity of degradation within the protein families engaged by the target ligand.
靶向蛋白质降解(TPD)是一种很有前景的药物开发策略。大多数降解剂的作用方式是促使靶蛋白(TP)与E3泛素(Ub)连接酶结合,在有利的情况下,这会导致TP的多聚泛素化及其随后被26S蛋白酶体降解。另一种策略是创建化学二聚体,通过将靶蛋白直接招募到蛋白酶体来绕过对多聚泛素化的需求。直接作用于蛋白酶体的降解剂(DPD)可能表现出与泛素依赖性降解剂不同的特性,但关于这类TPD的研究很少发表,主要是因为缺乏合适的蛋白酶体配体。为了促进对DPD的研究,我们在此报告一种哺乳动物细胞系,其中HaloTag蛋白通过泛素受体之一Rpn13与蛋白酶体融合。在这些细胞中,氯代烷烃作为共价蛋白酶体配体替代物。我们表明,由与BET家族蛋白或Cdk2/7/9家族激酶的配体连接的氯代烷烃组成的嵌合分子会导致其中一些靶蛋白的泛素非依赖性降解。我们使用这个系统——第一个允许以泛素非依赖性方式轻松降解天然蛋白质的系统——来探究两个问题:连接氯代烷烃和靶配体的接头长度变化的影响以及靶配体所涉及的蛋白质家族内降解的选择性。